Last Updated: 31-07-2025 | Format: PDF | Report ID:20327 | Author: Lena
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $14,900 Million |
| What is the projected market size by 2035? | $24,300 Million |
| What is the market CAGR from 2025 to 2035? | 5.0% |
| Which region dominates the market? | United States (73%) |
| Which product/service type dominates the market? | Diagnostic & Monitoring Devices (34%) |
| Which application leads the market? | Coronary Artery Disease (38%) |
| Who are the major buyers? | Hospitals (54%), Clinics (18%) |
| What are the key market growth drivers? | Rising incidence of cardiovascular disorders and increased demand for advanced treatment options; Technological advancements in imaging and digital health solutions |
| What are the major market challenges? | Stringent regulatory and reimbursement hurdles for novel cardiovascular technologies; High cost and complexity of implementing advanced technologies in smaller healthcare facilities |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? |
| Medtronic, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, GE Healthcare, Siemens Healthineers, Johnson & Johnson, Philips Healthcare, Terumo Corporation, B. Braun Melsungen AG, Cardinal Health, Stryker Corporation, Zoll Medical Corporation, MicroPort Scientific Corporation, LivaNova PLC |
Global Digital Biomarkers Market: by Type (Wearable Devices, Mobile Health Apps, Biosensors, Clinical Trials Platforms, Digital Diagnostics, Passive Monitoring Systems), Application (Cardiovascular Disease, Neurodegenerative Disorders, Diabetes, Respiratory Disease, Oncology, Others), Distribution Channels (Hospitals, Clinics, Research Centers, Homecare, Pharmacies, Online), Technology (Artificial Intelligence, Internet of Things, Machine Learning, Cloud Computing, Blockchain, Data Analytics), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Europe Clinical Trials Services Market: by Type (Drug, Device, Procedure, Behavioral, Observational, Others), Application (Oncology, Cardiovascular, Neurology, Infectious Diseases, Immunology, Others), Distribution Channels (Hospitals, Academic & Research Institutes, CROs, Pharmaceutical Companies, Medical Device Companies, Others), Technology (eClinical Solutions, Wearable Technology, Data Management Platforms, Remote Monitoring, Cloud-based Solutions, Artificial Intelligence), Organization Size (Small, Medium, Large) and By Europe – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Stem Cell Therapy Market Market: by Type (Allogeneic, Autologous), Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other Applications), Distribution Channels (Hospitals, Clinics, Academic & Research Institutes, Contract Research Organizations, Direct Sales, Online Channels), Technology (Stem Cell Acquisition, Stem Cell Preservation, Expansion, Sub-culture, Cryopreservation, Other Technologies), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global AI-Enabled Medical Devices Market: by Type (Diagnostic Devices, Therapeutic Devices, Monitoring Devices, Surgical Devices, Wearable Devices, Others), Application (Radiology, Cardiology, Neurology, Oncology, Orthopedics, Others), Distribution Channels (Online, Offline, Distributors, Retailers, Direct Sales, Others), Technology (Machine Learning, Natural Language Processing, Computer Vision, Robotics, Others, Cloud-Based Solutions), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Cell & Gene Therapy Manufacturing Services Market: by Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others), Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others), Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Others), Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025